ABCSG R05 Summary

Pre-operative induction-chemotherapy in combination with bevacizumab followed by combined radio-chemotherapy of local progressive rectal cancer with high relapse risk – a phase-II-pilot-study with pre-operative capecitabine (Xeloda®), oxaliplatin and bevacizumab (Avastin®), followed by capecitabine (Xeloda®) plus radiotherapy (RTx).

Start: quarter IV/2011
Finish: quarter IV/2012
Coordinating investigators: Eisterer, Wolfgang; Innsbruck
De Vries, Alexander; Feldkirch
Öfner, Dietmar; Salzburg
Sample size: 25
Design:
(Click to enlarge)
ABCSG-R05- Design